Gwendolyn Wu
ReporterGwendolyn is a reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.
194 articles by Gwendolyn Wu
-
Novo taps another Flagship startup in search for next obesity drugs
May 9, 2024 -
Prologue, Flagship’s newest startup, looks to mine viruses for new drugs
May 7, 2024 -
CG follows big IPO with new results for bladder cancer drug
May 3, 2024 -
Delphia starts up with $67M to make a new type of cancer drug
May 2, 2024 -
Enlaza gets JP Morgan, Regeneron backing for covalent biologics
April 30, 2024 -
Repertoire pivot pays dividends with Bristol Myers deal
April 29, 2024 -
Regeneron expands in gene editing with Mammoth deal
April 25, 2024 -
Endeavor pulls in $132M to back cancer, lung disease drugs
April 24, 2024 -
Canaan hires Pfizer executive, reels in $100M for biotech investing
April 17, 2024 -
Biotech landlord Alexandria on research clusters and the sector’s recovery
April 16, 2024 -
Biotech IPOs bounced back in first quarter, but backlog remains
April 12, 2024 -
Vertex to buy kidney disease drugmaker Alpine for $4.9B
April 10, 2024 -
Private biotech funding rises as venture firms deploy cash
April 8, 2024 -
Diagonal starts up with $128M to make better ‘activator’ antibody drugs
April 3, 2024 -
Ginkgo, in search of more cell therapy tools, buys another startup
April 2, 2024 -
Boundless Bio breaks IPO lull with $100M fundraise
March 28, 2024 -
SQZ, Portal founder Armon Sharei on starting over in biotech
March 26, 2024 -
Mirador debuts with $400M, picking up where immune drugmaker Prometheus left off
March 21, 2024 -
Clasp launches with $150M and a plan for precision cancer immunotherapies
March 20, 2024 -
German biotech Tubulis cashes in on ADC ‘momentum’ with €128M financing
March 14, 2024 -
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
March 7, 2024 -
European VC Invivo readies its latest fund to back new biotechs
March 6, 2024 -
Sionna raises another $182M to challenge Vertex in cystic fibrosis
March 6, 2024 -
Biotech IPOs heated up to start 2024. Will the surge last?
March 5, 2024 -
Nocion, chasing GSK, pulls in $62M for chronic cough drug
March 4, 2024